In contrast, knockout of TRPV2 can significantly increase cancer stem cell markers (CD133, CD44, and ALDH1) and enhance spheroid and colony formation in human hepatoma HepG2 cells [62]. The gene discussed is TRPV2; the disease is hepatocellular carcinoma.